Newsletters
RAMAT GAN, Israel, March 13, 2024 /PRNewswire/ — Pulsenmore (TASE: PULS), the global leader in self-testing ultrasound generation for home use and remote clinical diagnosis, announces its new clinical study collaboration with Michigan Medicine. The study will read into the ability to carry out remote biophysical profile (BPP) verification, Pulsenmore internal ultrasound with guidance from a remote clinician, which could reduce clinical burden.
Pulsenmore Home Prenatal Ultrasound allows pregnant women to connect their private smartphone to a dedicated device and app, allowing them to perform ultrasounds from the comfort of their home. These analyzes are seamlessly sent to the hospital for evaluation, focusing on fetal vitality parameters. The effects are then communicated to the patients. Doctors can interact with patients asynchronously or in real time, especially reducing the need for clinic visits.
Traditional prenatal tests, such as biophysical profiling (BPP), typically performed in a clinical setting, involve the evaluation of fetal parameters such as movement, tone, breathing, and fluid levels using ultrasound and combined with a relaxation test.
The study, conducted with Michigan Medicine, the University of Michigan Academic Medical Center, aims to compare whether patients can successfully perform GPP with the Pulsenmore device with the guidance of a remote physician. The good luck of the study can potentially lead to relief. The burden of medical care and an early pregnancy are reflected in patients due to issues such as transportation, rural residence, or the balance between childcare and work commitments.
Dr Alex Peahl, MD MSc, assistant professor and physician-scientist in the Department of Obstetrics and Gynaecology at the University of Michigan and principal investigator of the study, said: “Antenatal care delivery has undergone drastic adjustments since the COVID-19 pandemic. pandemic. Array adding immediate expansion into virtual prenatal visits. However, other people giving birth with complex pregnancies have not been able to reap the benefits of the increased flexibility, accessibility, and convenience of telemedicine due to the need for in-person fetal testing. It puts pregnancy monitoring equipment in the hands of patients, allowing them to perform complete biophysical profiles (BPPs) and fetal well-being tests, from anywhere. BPP four Me is the first step toward a new style of patient-centered prenatal care that can reduce the burden and barriers of care while empowering patients, especially those most marginalized through our existing healthcare system. “
To date, more than 100,000 tests have been successfully conducted with the Pulsenmore solution, proving its protection and reliability. Recent studies imply that the solution can access care and reduce the length of clinic visits by 63%, decrease maternal anxiety and maternal bonding. as well as contributing to a greater pregnancy experience with greater patient satisfaction.
Pulsenmore recently announced a commitment agreement with ‘Sheba BEYOND’ virtual hospital. Sheba Medical Center, known for its excellence in healthcare, will utilize Pulsenmore’s solution at ‘BEYOND’ as part of its’ obstetrics department, offering top-quality medical services to high-risk pregnancy insured individuals.
Pulsenmore has marketing approvals in Europe, the United Kingdom, Switzerland, Israel, Australia and Brazil. The company continues to expand its operations by expanding its distribution and collaborations with healthcare organizations in key markets.
For more information, visit www. pulsenmore. com
Mira Altmark-Sofer, VP Marketing [email protected]
Video: https://www. youtube. com/watch?v=gzILwjkm. . .
See content to download multimedia: https://www. prnewswire. co. uk/news-releases/pulsenmore-is-expanding-the-application-of-its-home-ultrasound-solution-for-pregnant-women-un -clinical-trial-with-Michigan-medicine-will-focus-on-remote-evaluation-du-profil-biophysique-fœtal-302088105. html
Portal de actualidad y noticias de la Agencia Europa Press.